Correlation Between Immune Metabolism in Patients With Benzodiazepine Poisoning and Patients'Mental Disorders
NCT05184959 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2022-01-11
Summary
High-dose benzodiazepines can inhibit the central nervous system, respiratory system and cardiovascular motor center, resulting in loss of consciousness, disappearance of reflex, respiratory inhibition, decrease of blood pressure and so on. This kind of drug acute poisoning is the most common drug poisoning in internal medicine. It has acute onset and severe symptoms. If it is not treated properly in time, it can be life-threatening. At present, the research on the accumulation and metabolic state caused by benzodiazepine poisoning is not sufficient; at the same time, the changes of neuroendocrine metabolism and immune function of patients with neuroendocrine metabolism and immune function need to be further explored. Therefore, the main purpose of this study is to analyze the effects of neuroendocrine metabolism and immune function on organ function and mental state in patients with benzodiazepine poisoning.
Conditions
- Poisoning by Benzodiazepines
- Depression
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-01
- Primary Completion
- 2022-06-01
- Completion
- 2022-12-01
More Related Trials
-
Opioid/Benzodiazepine Polydrug Abuse
NCT03696017 ·Status: RECRUITING
-
Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users
NCT06446349 ·Status: RECRUITING ·Phase: NA
-
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity
NCT03829839 ·Status: COMPLETED ·Phase: PHASE1
-
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
NCT00058955 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280
NCT00681746 ·Status: COMPLETED ·Phase: PHASE1
-
Benzo[a]Pyrene Ultralow Dose-Response Study
NCT03318978 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up
NCT02827331 ·Status: COMPLETED
-
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
NCT05219604 ·Status: TERMINATED ·Phase: PHASE4
-
Clonidine vs. Dexmedetomidine in Agitated Delirium in Intensive Care Patients
NCT04758936 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users
NCT03509285 ·Status: COMPLETED ·Phase: PHASE1
-
Prescription of Benzodiazepines by General Practitioners: Characteristics of Prescribing Trend and Implementation of an Online Educational Program
NCT04925596 ·Status: COMPLETED ·Phase: NA
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
NCT03090620 ·Status: COMPLETED ·Phase: PHASE4
-
Staccato Alprazolam Abuse Liability
NCT00603980 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
NCT05974527 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
NCT04113343 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Analysis of Drug Burden Index
NCT03024541 ·Status: COMPLETED
-
Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients
NCT03369639 ·Status: WITHDRAWN
-
Lorazepam-Induced Toxicity in the Aged
NCT00044642 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 ·Status: COMPLETED ·Phase: PHASE1
-
Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
NCT01501591 ·Status: COMPLETED ·Phase: NA
-
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981 ·Status: COMPLETED
-
Effects of Diacetylmorphine (DAM) on Brain Function and Stress Response
NCT01174927 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine IV Classic Protocol : Five Years Follow up
NCT04824157 ·Status: COMPLETED